NEWS LABORATORY INFORMATICS
Nobel Prize in Chemistry 2021 for editor and authors of Thieme Chemistry
This year’s Nobel Prize in Chemistry goes to Benjamin List, Germany, and David MacMillan, USA, for the development of asymmetric organocatalysis. In 2013, Benjamin List published a two-volume work on this topic with Thieme. As editor-in-chief of the journal SYNLETT of Thieme Chemistry, he has been largely responsible for its content since 2015. Furthermore, List has been an active member of the editorial board of the journal SYNFACTS since 2006. David MacMillan is the author of several chapters in Science of Synthesis, Thieme’s digital reference work for organic synthetic chemistry. For SYNLETT, he authored the paper, ‘Strategies to Bypass the Taxol Problem.’ In 2006, he received the Thieme IUPAC Prize. Catalysts are substances that enable
and accelerate chemical reactions, but are not consumed in the reaction process itself. Therefore, catalysts are fundamental tools for chemists in research and industry. For a long time, only two types of catalysts were known: metal complexes and enzymes. In 2000, Benjamin List and David MacMillan independently developed a third possibility: the so- called asymmetric organocatalysis. For this achievement, both scientists have now been awarded the Nobel Prize in Chemistry 2021, which is endowed with a
HIGH-PERFORMANCE COMPUTING HCL partners with Google Cloud
HCL Technologies (HCL) has expanded its strategic partnership with Google Cloud to launch healthcare and life sciences solutions.
HCL will establish a joint
centre of excellence (CoE) for Google Cloud with industry subject matter experts to deliver solutions for payer, provider, medtech and biopharma customers. HCL’s Google Cloud Native Labs will help accelerate these solutions with Google Cloud support, which provides AI and its security capabilities across the healthcare and life sciences value chain. Joe Miles, managing
director, cloud healthcare and life sciences, Google Cloud,
added: ‘We’re excited to see our partnership with HCL grow as we continue to build solutions that will help organisations digitally transform the processes and experiences of their customers, physicians and patients. Customers can leverage HCL’s strong healthcare and life sciences industry expertise and their investments in the centre of excellence for Google Cloud to support their growth and innovation objectives.’ HCL’s CoE will develop
solutions that address critical industry issues, such as interoperability, data governance and security. Kevin Ichhpurani, corporate vice president, partner ecosystem,
www.scientific-computing.com | @scwmagazine
Google Cloud, comments: ‘As the healthcare and life sciences industry continues to digitally transform, there is a growing need for solutions that are cloud-native, secure and support innovation. We are pleased to expand our partnership with HCL to provide our customers with solutions that will help throughout their cloud transformations.’ Shrikanth Shetty,
corporate vice president, HCL Technologies, said: ‘We partnered with Google Cloud for this key initiative because it will enable our experts at HCL to incorporate decades of domain expertise to deliver cutting- edge, cloud-native solutions
to the market. The partnership will help improve the patient and employee experiences and use data to drive insights in areas like claims management and servitisation.’ Sanjay Singh, senior vice
president and global head, HCL Google Ecosystem, HCL Technologies, said: ‘HCL and Google Cloud’s ecosystem is focused on helping our customers innovate by leveraging the power of Google Cloud. We will leverage our Google Cloud Native Labs to deliver rapid MVPs and solutions that will accelerate our healthcare and life sciences customers’ digital transformations.’
Autumn 2021 Scientific Computing World 29
total of around 980,000 Euros. Pernilla Wittung-Stafshede in the Nobel Committee’s citation comments: ‘The laureates have developed a truly elegant tool for making molecules – simpler than one could ever imagine. It is already benefiting humankind greatly.’ The process makes it possible to use small organic substances as catalysts and thus make the production of molecules cheaper, safer and more environmentally friendly. For example, researchers
“Catalysts are fundamental tools for chemists in research and industry”
can produce molecules needed for the production and development of pharmaceuticals more quickly and efficiently. Organocatalysis is now recognised worldwide as the third class of catalysis principles and has undergone rapid development since its introduction. Benjamin List and David MacMillan continue to be leaders in this field. Nobel prize Laureate Benjamin List is
director of the Max Planck Institute for Coal Research in Mülheim an der Ruhr. In 2011, he joined the editorial board of
SYNLETT. In 2013, he co-edited with Keiji Maruoka a two-volume edition on asymmetric organocatalysis as part of Thieme’s Science of Synthesis (SOS) Reference Library. List is also the mastermind and
developer of the Select Crowd Review process, which combines up to date peer review with innovative technology. Select Crowd Review is used in SYNLETT and several other Thieme journals. Nobel prize laureate David MacMillan is
a professor at Princeton University, US. As an expert in stereoselective synthesis, he has authored several chapters for Science of Synthesis, Thieme’s curated and digital reference work on synthetic organic chemistry. SOS addresses the information needs of organic chemists and is a helpful resource for all those involved in designing synthetic routes, whether for research purposes or teaching and/or learning, by providing trusted and reliable information on the best synthetic methods available. In 2006, he received the Thieme–IUPAC Prize, which is awarded every two years at the International Union of Pure and Applied Chemistry – International Conference on Organic Synthesis (IUPAC–ICOS). You will find freely accessible articles by Benjamin List and David MacMillan here: Thieme E-Books & E-Journals – Synlett/ Edition (
thieme-connect.com).
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34